ICBMT 2025

HOME

Scientific Program

SELECT AND VIEW SESSIONS OF YOUR CHOICE
Search

[JS03] Joint Symposium 3 (East Asia Collaborative Session): Stem Cell Transplantation in Diffuse Large B-cell Lymphoma in the Era of Immunotherapy

September 12 (Fri), 10:10-11:50 		Room A
Chair(s) TBD
  • Jieun Uhm

    10:10-10:35

    Optimizing Autologous Stem Cell Transplantation in the Age of CAR T-cell Therapy: Still a Standard?

    Jieun Uhm

    Hanyang University College of Medicine, Korea

  • Shinichi Makita

    10:35-11:00

    Treatment Options after CAR T-cell Failure in Diffuse Large B-cell Lymphoma

    Shinichi Makita

    National Cancer Center Hospital, Japan

  • TBD

    11:00-11:25

    Integration of Stem Cell Transplant, CAR T-cell, and Next-generation Immunotherapies in High-grade B-cell Lymphoma

    TBD

  • Tai-Chung Huang

    11:25-11:50

    Immune Reconstitution after CAR T-cell Therapy vs. Stem Cell Transplantation: Mechanistic Insights and Clinical Implications

    Tai-Chung Huang

    National Taiwan University Hospital, Taiwan

    CV

[SS05] Scientific Session 5 (KAICET-Cell Therapy Committee Joint Session): Next-Generation Immune Cell Therapies: From Design to Clinical Application

September 12 (Fri), 10:10-11:40 		Room B
Chair(s) TBD
  • Hyung Cheol Kim

    10:10-10:40

    Development of Armored CAR-T Cell Therapeutics for Solid Tumors

    Hyung Cheol Kim

    Curocell Inc., Korea

    CV
  • Eun Young Choi

    10:40-11:10

    Immune Synapse Potentiating Novel CAR Structure-based Anti-CD19 CAR T Cells 

    Eun Young Choi

    Seoul National University College of Medicine, Korea

  • Katy Rezvani

    11:10-11:40

    From Bench to Bedside: The Promise of Engineered NK Cell Therapy

    Katy Rezvani

    The University of Texas MD Anderson Cancer Center, USA

    Abstract CV

[SS06] Scientific Session 6: GVHD Update: Evolving Paradigms in Diagnosis and Therapy

September 12 (Fri), 10:10-11:40 		Room C
Chair(s) TBD
  • Guang-Shing Cheng

    10:10-10:40

    Clinical Approach of GvHD Bronchiolitis Obliterans Syndrome - Focusing on Early Detection, Diagnosis, Treatment Approach

    Guang-Shing Cheng

    University of Washington School of Medicine, USA

    CV
  • Corey Cutler

    10:40-11:10

    Emerging Therapies in GVHD and Future Direction (GVHD Treatment Paradigms: Promising Agents Nearing Clinical Use)

    Corey Cutler

    Dana-Farber / Harvard Cancer Center, USA

    CV
  • Robert Zeiser

    11:10-11:40

    Novel Therapies for Chronic GVHD

    Robert Zeiser

    University Medical Center Freiburg, Germany

    Abstract CV

[ES02] Education Session 2: Smart Research Practices: From Data Analysis to Writing

September 12 (Fri), 10:10-11:40 		Room D
Chair(s) TBD
  • Yohan Koo

    10:10-10:40

    Medical Research and Scientific Writing using AI

    Yohan Koo

    CHA University, Korea

  • Mohamad Mohty

    10:40-11:10

    Scientific Writing in BMT and Cellular Therapy Research

    Mohamad Mohty

    Saint-Antoine Hospital, France

    CV
  • Yoshinobu Kanda

    11:10-11:40

    Application of R Statistics in HSCT Research (EZR)

    Yoshinobu Kanda

    Jichi Medical University, Japan

    CV

[SS07] Scientific Session 7: Transplantation and Relapse: Evidence and Practice Updates

September 12 (Fri), 13:00-14:30 		Room A
Chair(s) TBD
  • Partow Kebriaei

    13:00-13:30

    Strategies to Reduce Relapse after HSCT in ALL Patients

    Partow Kebriaei

    The University of Texas MD Anderson Cancer Center, USA

    CV
  • TBD

    13:30-14:00

    Menin Inhibitors in High-Risk AML: Bridging to Transplant and Beyond

    TBD

  • Silvia Park

    14:00-14:30

    Donor Lymphocyte Infusion Strategy: Korean Institutional Perspective

    Silvia Park

    College of Medicine, The Catholic University of Korea, Korea

[SS08] Pediatric

September 12 (Fri), 13:00-14:30 		Room B
Chair(s) TBD
  • TBD

    13:00-13:30

    Allogeneic CAR T-cell Therapies

    TBD

  • Krzysztof Kalwak

    13:30-14:00

    The Optimal Conditioning for Allo-HSCT in Children with ALL (FORUM Trial)

    Krzysztof Kalwak

    Wroclaw Medical University, Poland

    CV
  • Jae Won Yoo

    14:00-14:30

    Management of Post-HSCT Relapse in Pediatric Leukemia

    Jae Won Yoo

    College of Medicine, The Catholic University of Korea, Korea

    CV

[NS01] Nursing Session 1: Multidisciplinary Approach to Treatment after Hematopoietic Stem Cell Transplantation l (KOR.)

September 12 (Fri), 13:00-14:30 		Room C
Chair(s) EunJung Joo (National Cancer Center, Korea)
  • Daham Kim

    13:00-13:30

    Optimizing Endocrine Outcomes after Hematopoietic Stem Cell Transplantation

    Daham Kim

    Yonsei University College of Medicine, Korea

    CV
  • Junseok Jeon

    13:30-14:00

    Acute Kidney Injury after Hematopoietic Stem Cell Transplantation

    Junseok Jeon

    Sungkyunkwan University School of Medicine, Korea

    CV
  • Eun-Seung Yu

    14:00-14:30

    Psychosocial Distress in Hematopoietic Stem Cell Transplantation

    Eun-Seung Yu

    The Cyber University of Korea, Korea

    CV

[ES03] Education Session 3: Optimizing Outcomes in HSCT

September 12 (Fri), 13:00-14:30 		Room D
Chair(s) TBD
  • Yong Park

    13:00-13:30

    Intensity of Conditioning Regimen (Evolution of Conditioning Regimen)

    Yong Park

    Korea University College of Medicine, Korea

  • Joon Ho Moon

    13:30-14:00

    Advances in GVHD Prophylaxis: From ATG to Post-Transplant Cyclophosphamide (PTCy)

    Joon Ho Moon

    Kyungpook National University School of Medicine, Korea

  • Daehun Kwag

    14:00-14:30

    Second Malignancy after HSCT

    Daehun Kwag

    College of Medicine, The Catholic University of Korea, Korea

[PS01] Presidential Symposium

September 12 (Fri), 14:40-15:20 		Room A
Chair(s) TBD
  • Soheil Meshinchi

    14:40-15:20

    AML-Specific Therapeutics: Integrating Risk-Stratified Transplantation and Immunotherapeutic Targeting

    Soheil Meshinchi

    Fred Hutchinson Cancer Center, USA

    CV

[PL03] Plenary Session 3

September 12 (Fri), 15:20-16:00 		Room A
Chair(s) TBD
  • Mohamad Mohty

    15:20-16:00

    Personalized Conditioning Strategies in Allogeneic HSCT: Balancing Disease Control and Toxicity Across Age Groups

    Mohamad Mohty

    Saint-Antoine Hospital, France

    CV

[DS01] Debate Session 1: Splenectomy Prior to HSCT in in Myelofibrosis: Necessity or Risk?

September 12 (Fri), 16:40-18:20 		Room A
Chair(s) TBD
  • Ik-Chan Song

    16:40-16:55

    Necessity

    Ik-Chan Song

    Chungnam National University College of Medicine, Korea

    CV
  • Yunsuk Choi

    16:55-17:10

    Risk

    Yunsuk Choi

    University of Ulsan College of Medicine, Korea

[DS02] Debate Session 2: Donor Selection for HSCT in Pediatric Leukemia: Haploidentical versus Other Alternative Donor

September 12 (Fri), 16:40-18:20 		Room A
Chair(s) TBD
  • Sung Han Kang

    17:30-17:45

    Haploidentical

    Sung Han Kang

    University of Ulsan College of Medicine, Korea

  • Kyung Taek Hong

    17:45-18:00

    Other Alternative Donor

    Kyung Taek Hong

    Seoul National University College of Medicine, Korea

    CV

[JS04] Joint Symposium 4 (JSTCT-KSBMT): Transplant Strategies to Overcome MRD Positive Hematologic Malignancies

September 12 (Fri), 16:40-18:20 		Room C
Chair(s) TBD
  • TBD

    16:40-17:05

    Inter-methodological Discrepancies and a Definition of MRD Response

    TBD

  • Yu Akahoshi

    17:05-17:30

    Transplantation & Management of High-risk ALL with Poor MRD Response

    Yu Akahoshi

    National Cancer Center Hospital, Japan

    CV
  • Ari Ahn

    17:30-17:55

    Integrating Flow Cytometry-Based MRD into Transplant and Maintenance Strategies in MM

    Ari Ahn

    College of Medicine, The Catholic University of Korea, Korea

    CV
  • Hyunsoo Cho

    17:55-18:20

    Transplantation & Management of High-risk MM with Poor MRD Response

    Hyunsoo Cho

    Yonsei University College of Medicine, Korea

    CV

[ES04] Education Session 4: Infectious Complication

September 12 (Fri), 16:40-18:10 		Room D
Chair(s) TBD
  • Seung-Ji Kang

    16:40-17:10

    Viral Infection after HSCT

    Seung-Ji Kang

    Chonnam National University Medical School, Korea

  • Ji Hyun Lee

    17:10-17:40

    Infection Prophylaxis in CAR T Cell Therapy

    Ji Hyun Lee

    Dong-A University Hospital, Korea

  • Annalisa Paviglianiti

    17:40-18:10

    Should a Well-Cooked Diet Be Recommended for Transplant Patients?

    Annalisa Paviglianiti

    Hospital de la Santa Creu i Sant Pau, Spain

    CV